世界の多剤耐性菌治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Multidrug Resistant Bacteria Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4531
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、124ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、多剤耐性菌治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口、その他）、用途別市場規模（病院、専門クリニック、リカバリーセンター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・多剤耐性菌治療の市場動向
・企業の競争状況、市場シェア
・多剤耐性菌治療の種類別市場規模と予測2016-2027（経口、非経口、その他）
・多剤耐性菌治療の用途別市場規模と予測2016-2027（病院、専門クリニック、リカバリーセンター）
・多剤耐性菌治療の北米市場規模2016-2027（アメリカ、カナダ）
・多剤耐性菌治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・多剤耐性菌治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・多剤耐性菌治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・多剤耐性菌治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Nabriva Therapeutics、BioVersys、Johnson & Johnson、Destiny Pharma、Armata Pharmaceuticals、Westway Health、Nemesis Bioscience、Tetraphase Pharmaceuticals、Allergan、Merck、Pfizer、CARB-X、Melinta Therapeutics、Novartis、Vertex Pharmaceuticals Incorporated、GlaxoSmithKline、AbbVie、Roche）
・結論

It is an antibiotic used to treat infections caused by multi-drug resistant bacteria.

Market Analysis and Insights: Global Multidrug Resistant Bacteria Treatment Market
The global Multidrug Resistant Bacteria Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Multidrug Resistant Bacteria Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Multidrug Resistant Bacteria Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Multidrug Resistant Bacteria Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Multidrug Resistant Bacteria Treatment market.

Global Multidrug Resistant Bacteria Treatment Scope and Market Size
Multidrug Resistant Bacteria Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Multidrug Resistant Bacteria Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Parenteral
Others

Segment by Application
Hospital
Special Clinic
Recovery Center

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Nabriva Therapeutics
BioVersys
Johnson & Johnson
Destiny Pharma
Armata Pharmaceuticals
Westway Health
Nemesis Bioscience
Tetraphase Pharmaceuticals
Allergan
Merck
Pfizer
CARB-X
Melinta Therapeutics
Novartis
Vertex Pharmaceuticals Incorporated
GlaxoSmithKline
AbbVie
Roche

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multidrug Resistant Bacteria Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Parenteral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Multidrug Resistant Bacteria Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Special Clinic
1.3.4 Recovery Center
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Multidrug Resistant Bacteria Treatment Market Perspective (2016-2027)
2.2 Multidrug Resistant Bacteria Treatment Growth Trends by Regions
2.2.1 Multidrug Resistant Bacteria Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Multidrug Resistant Bacteria Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Multidrug Resistant Bacteria Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Multidrug Resistant Bacteria Treatment Industry Dynamic
2.3.1 Multidrug Resistant Bacteria Treatment Market Trends
2.3.2 Multidrug Resistant Bacteria Treatment Market Drivers
2.3.3 Multidrug Resistant Bacteria Treatment Market Challenges
2.3.4 Multidrug Resistant Bacteria Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Multidrug Resistant Bacteria Treatment Players by Revenue
3.1.1 Global Top Multidrug Resistant Bacteria Treatment Players by Revenue (2016-2021)
3.1.2 Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Multidrug Resistant Bacteria Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Multidrug Resistant Bacteria Treatment Revenue
3.4 Global Multidrug Resistant Bacteria Treatment Market Concentration Ratio
3.4.1 Global Multidrug Resistant Bacteria Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multidrug Resistant Bacteria Treatment Revenue in 2020
3.5 Multidrug Resistant Bacteria Treatment Key Players Head office and Area Served
3.6 Key Players Multidrug Resistant Bacteria Treatment Product Solution and Service
3.7 Date of Enter into Multidrug Resistant Bacteria Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Multidrug Resistant Bacteria Treatment Breakdown Data by Type
4.1 Global Multidrug Resistant Bacteria Treatment Historic Market Size by Type (2016-2021)
4.2 Global Multidrug Resistant Bacteria Treatment Forecasted Market Size by Type (2022-2027)

5 Multidrug Resistant Bacteria Treatment Breakdown Data by Application
5.1 Global Multidrug Resistant Bacteria Treatment Historic Market Size by Application (2016-2021)
5.2 Global Multidrug Resistant Bacteria Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Multidrug Resistant Bacteria Treatment Market Size (2016-2027)
6.2 North America Multidrug Resistant Bacteria Treatment Market Size by Type
6.2.1 North America Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2021)
6.2.2 North America Multidrug Resistant Bacteria Treatment Market Size by Type (2022-2027)
6.2.3 North America Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2027)
6.3 North America Multidrug Resistant Bacteria Treatment Market Size by Application
6.3.1 North America Multidrug Resistant Bacteria Treatment Market Size by Application (2016-2021)
6.3.2 North America Multidrug Resistant Bacteria Treatment Market Size by Application (2022-2027)
6.3.3 North America Multidrug Resistant Bacteria Treatment Market Size by Application (2016-2027)
6.4 North America Multidrug Resistant Bacteria Treatment Market Size by Country
6.4.1 North America Multidrug Resistant Bacteria Treatment Market Size by Country (2016-2021)
6.4.2 North America Multidrug Resistant Bacteria Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Multidrug Resistant Bacteria Treatment Market Size (2016-2027)
7.2 Europe Multidrug Resistant Bacteria Treatment Market Size by Type
7.2.1 Europe Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2021)
7.2.2 Europe Multidrug Resistant Bacteria Treatment Market Size by Type (2022-2027)
7.2.3 Europe Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2027)
7.3 Europe Multidrug Resistant Bacteria Treatment Market Size by Application
7.3.1 Europe Multidrug Resistant Bacteria Treatment Market Size by Application (2016-2021)
7.3.2 Europe Multidrug Resistant Bacteria Treatment Market Size by Application (2022-2027)
7.3.3 Europe Multidrug Resistant Bacteria Treatment Market Size by Application (2016-2027)
7.4 Europe Multidrug Resistant Bacteria Treatment Market Size by Country
7.4.1 Europe Multidrug Resistant Bacteria Treatment Market Size by Country (2016-2021)
7.4.2 Europe Multidrug Resistant Bacteria Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size (2016-2027)
8.2 Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Type
8.2.1 Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Application
8.3.1 Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Region
8.4.1 Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Multidrug Resistant Bacteria Treatment Market Size (2016-2027)
9.2 Latin America Multidrug Resistant Bacteria Treatment Market Size by Type
9.2.1 Latin America Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Multidrug Resistant Bacteria Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2027)
9.3 Latin America Multidrug Resistant Bacteria Treatment Market Size by Application
9.3.1 Latin America Multidrug Resistant Bacteria Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Multidrug Resistant Bacteria Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Multidrug Resistant Bacteria Treatment Market Size by Application (2016-2027)
9.4 Latin America Multidrug Resistant Bacteria Treatment Market Size by Country
9.4.1 Latin America Multidrug Resistant Bacteria Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Multidrug Resistant Bacteria Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size (2016-2027)
10.2 Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Type
10.2.1 Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Application
10.3.1 Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Country
10.4.1 Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Nabriva Therapeutics
11.1.1 Nabriva Therapeutics Company Details
11.1.2 Nabriva Therapeutics Business Overview
11.1.3 Nabriva Therapeutics Multidrug Resistant Bacteria Treatment Introduction
11.1.4 Nabriva Therapeutics Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.1.5 Nabriva Therapeutics Recent Development
11.2 BioVersys
11.2.1 BioVersys Company Details
11.2.2 BioVersys Business Overview
11.2.3 BioVersys Multidrug Resistant Bacteria Treatment Introduction
11.2.4 BioVersys Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.2.5 BioVersys Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Multidrug Resistant Bacteria Treatment Introduction
11.3.4 Johnson & Johnson Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Destiny Pharma
11.4.1 Destiny Pharma Company Details
11.4.2 Destiny Pharma Business Overview
11.4.3 Destiny Pharma Multidrug Resistant Bacteria Treatment Introduction
11.4.4 Destiny Pharma Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.4.5 Destiny Pharma Recent Development
11.5 Armata Pharmaceuticals
11.5.1 Armata Pharmaceuticals Company Details
11.5.2 Armata Pharmaceuticals Business Overview
11.5.3 Armata Pharmaceuticals Multidrug Resistant Bacteria Treatment Introduction
11.5.4 Armata Pharmaceuticals Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.5.5 Armata Pharmaceuticals Recent Development
11.6 Westway Health
11.6.1 Westway Health Company Details
11.6.2 Westway Health Business Overview
11.6.3 Westway Health Multidrug Resistant Bacteria Treatment Introduction
11.6.4 Westway Health Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.6.5 Westway Health Recent Development
11.7 Nemesis Bioscience
11.7.1 Nemesis Bioscience Company Details
11.7.2 Nemesis Bioscience Business Overview
11.7.3 Nemesis Bioscience Multidrug Resistant Bacteria Treatment Introduction
11.7.4 Nemesis Bioscience Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.7.5 Nemesis Bioscience Recent Development
11.8 Tetraphase Pharmaceuticals
11.8.1 Tetraphase Pharmaceuticals Company Details
11.8.2 Tetraphase Pharmaceuticals Business Overview
11.8.3 Tetraphase Pharmaceuticals Multidrug Resistant Bacteria Treatment Introduction
11.8.4 Tetraphase Pharmaceuticals Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.8.5 Tetraphase Pharmaceuticals Recent Development
11.9 Allergan
11.9.1 Allergan Company Details
11.9.2 Allergan Business Overview
11.9.3 Allergan Multidrug Resistant Bacteria Treatment Introduction
11.9.4 Allergan Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.9.5 Allergan Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Multidrug Resistant Bacteria Treatment Introduction
11.10.4 Merck Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.10.5 Merck Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Multidrug Resistant Bacteria Treatment Introduction
11.11.4 Pfizer Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.11.5 Pfizer Recent Development
11.12 CARB-X
11.12.1 CARB-X Company Details
11.12.2 CARB-X Business Overview
11.12.3 CARB-X Multidrug Resistant Bacteria Treatment Introduction
11.12.4 CARB-X Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.12.5 CARB-X Recent Development
11.13 Melinta Therapeutics
11.13.1 Melinta Therapeutics Company Details
11.13.2 Melinta Therapeutics Business Overview
11.13.3 Melinta Therapeutics Multidrug Resistant Bacteria Treatment Introduction
11.13.4 Melinta Therapeutics Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.13.5 Melinta Therapeutics Recent Development
11.14 Novartis
11.14.1 Novartis Company Details
11.14.2 Novartis Business Overview
11.14.3 Novartis Multidrug Resistant Bacteria Treatment Introduction
11.14.4 Novartis Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.14.5 Novartis Recent Development
11.15 Vertex Pharmaceuticals Incorporated
11.15.1 Vertex Pharmaceuticals Incorporated Company Details
11.15.2 Vertex Pharmaceuticals Incorporated Business Overview
11.15.3 Vertex Pharmaceuticals Incorporated Multidrug Resistant Bacteria Treatment Introduction
11.15.4 Vertex Pharmaceuticals Incorporated Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.15.5 Vertex Pharmaceuticals Incorporated Recent Development
11.16 GlaxoSmithKline
11.16.1 GlaxoSmithKline Company Details
11.16.2 GlaxoSmithKline Business Overview
11.16.3 GlaxoSmithKline Multidrug Resistant Bacteria Treatment Introduction
11.16.4 GlaxoSmithKline Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.16.5 GlaxoSmithKline Recent Development
11.17 AbbVie
11.17.1 AbbVie Company Details
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Multidrug Resistant Bacteria Treatment Introduction
11.17.4 AbbVie Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.17.5 AbbVie Recent Development
11.18 Roche
11.18.1 Roche Company Details
11.18.2 Roche Business Overview
11.18.3 Roche Multidrug Resistant Bacteria Treatment Introduction
11.18.4 Roche Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021)
11.18.5 Roche Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Multidrug Resistant Bacteria Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Parenteral
Table 4. Key Players of Others
Table 5. Global Multidrug Resistant Bacteria Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Multidrug Resistant Bacteria Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Multidrug Resistant Bacteria Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Multidrug Resistant Bacteria Treatment Market Share by Regions (2016-2021)
Table 9. Global Multidrug Resistant Bacteria Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Multidrug Resistant Bacteria Treatment Market Share by Regions (2022-2027)
Table 11. Multidrug Resistant Bacteria Treatment Market Trends
Table 12. Multidrug Resistant Bacteria Treatment Market Drivers
Table 13. Multidrug Resistant Bacteria Treatment Market Challenges
Table 14. Multidrug Resistant Bacteria Treatment Market Restraints
Table 15. Global Multidrug Resistant Bacteria Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Multidrug Resistant Bacteria Treatment Market Share by Players (2016-2021)
Table 17. Global Top Multidrug Resistant Bacteria Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multidrug Resistant Bacteria Treatment as of 2020)
Table 18. Ranking of Global Top Multidrug Resistant Bacteria Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Multidrug Resistant Bacteria Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Multidrug Resistant Bacteria Treatment Product Solution and Service
Table 22. Date of Enter into Multidrug Resistant Bacteria Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Multidrug Resistant Bacteria Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Multidrug Resistant Bacteria Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Multidrug Resistant Bacteria Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Multidrug Resistant Bacteria Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Multidrug Resistant Bacteria Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Multidrug Resistant Bacteria Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Multidrug Resistant Bacteria Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Multidrug Resistant Bacteria Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Multidrug Resistant Bacteria Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Multidrug Resistant Bacteria Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Multidrug Resistant Bacteria Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Multidrug Resistant Bacteria Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Multidrug Resistant Bacteria Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Multidrug Resistant Bacteria Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Multidrug Resistant Bacteria Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Multidrug Resistant Bacteria Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Multidrug Resistant Bacteria Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Multidrug Resistant Bacteria Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Nabriva Therapeutics Company Details
Table 63. Nabriva Therapeutics Business Overview
Table 64. Nabriva Therapeutics Multidrug Resistant Bacteria Treatment Product
Table 65. Nabriva Therapeutics Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 66. Nabriva Therapeutics Recent Development
Table 67. BioVersys Company Details
Table 68. BioVersys Business Overview
Table 69. BioVersys Multidrug Resistant Bacteria Treatment Product
Table 70. BioVersys Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 71. BioVersys Recent Development
Table 72. Johnson & Johnson Company Details
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Multidrug Resistant Bacteria Treatment Product
Table 75. Johnson & Johnson Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 76. Johnson & Johnson Recent Development
Table 77. Destiny Pharma Company Details
Table 78. Destiny Pharma Business Overview
Table 79. Destiny Pharma Multidrug Resistant Bacteria Treatment Product
Table 80. Destiny Pharma Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 81. Destiny Pharma Recent Development
Table 82. Armata Pharmaceuticals Company Details
Table 83. Armata Pharmaceuticals Business Overview
Table 84. Armata Pharmaceuticals Multidrug Resistant Bacteria Treatment Product
Table 85. Armata Pharmaceuticals Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 86. Armata Pharmaceuticals Recent Development
Table 87. Westway Health Company Details
Table 88. Westway Health Business Overview
Table 89. Westway Health Multidrug Resistant Bacteria Treatment Product
Table 90. Westway Health Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 91. Westway Health Recent Development
Table 92. Nemesis Bioscience Company Details
Table 93. Nemesis Bioscience Business Overview
Table 94. Nemesis Bioscience Multidrug Resistant Bacteria Treatment Product
Table 95. Nemesis Bioscience Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 96. Nemesis Bioscience Recent Development
Table 97. Tetraphase Pharmaceuticals Company Details
Table 98. Tetraphase Pharmaceuticals Business Overview
Table 99. Tetraphase Pharmaceuticals Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 100. Tetraphase Pharmaceuticals Recent Development
Table 101. Allergan Company Details
Table 102. Allergan Business Overview
Table 103. Allergan Multidrug Resistant Bacteria Treatment Product
Table 104. Allergan Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 105. Allergan Recent Development
Table 106. Merck Company Details
Table 107. Merck Business Overview
Table 108. Merck Multidrug Resistant Bacteria Treatment Product
Table 109. Merck Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 110. Merck Recent Development
Table 111. Pfizer Company Details
Table 112. Pfizer Business Overview
Table 113. Pfizer Multidrug Resistant Bacteria Treatment Product
Table 114. Pfizer Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 115. Pfizer Recent Development
Table 116. CARB-X Company Details
Table 117. CARB-X Business Overview
Table 118. CARB-X Multidrug Resistant Bacteria Treatment Product
Table 119. CARB-X Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 120. CARB-X Recent Development
Table 121. Melinta Therapeutics Company Details
Table 122. Melinta Therapeutics Business Overview
Table 123. Melinta Therapeutics Multidrug Resistant Bacteria Treatment Product
Table 124. Melinta Therapeutics Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 125. Melinta Therapeutics Recent Development
Table 126. Novartis Company Details
Table 127. Novartis Business Overview
Table 128. Novartis Multidrug Resistant Bacteria Treatment Product
Table 129. Novartis Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 130. Novartis Recent Development
Table 131. Vertex Pharmaceuticals Incorporated Company Details
Table 132. Vertex Pharmaceuticals Incorporated Business Overview
Table 133. Vertex Pharmaceuticals Incorporated Multidrug Resistant Bacteria Treatment Product
Table 134. Vertex Pharmaceuticals Incorporated Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 135. Vertex Pharmaceuticals Incorporated Recent Development
Table 136. GlaxoSmithKline Company Details
Table 137. GlaxoSmithKline Business Overview
Table 138. GlaxoSmithKline Multidrug Resistant Bacteria Treatment Product
Table 139. GlaxoSmithKline Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 140. GlaxoSmithKline Recent Development
Table 141. AbbVie Company Details
Table 142. AbbVie Business Overview
Table 143. AbbVie Multidrug Resistant Bacteria Treatment Product
Table 144. AbbVie Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 145. AbbVie Recent Development
Table 146. Roche Company Details
Table 147. Roche Business Overview
Table 148. Roche Multidrug Resistant Bacteria Treatment Product
Table 149. Roche Revenue in Multidrug Resistant Bacteria Treatment Business (2016-2021) & (US$ Million)
Table 150. Roche Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multidrug Resistant Bacteria Treatment Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Parenteral Features
Figure 4. Others Features
Figure 5. Global Multidrug Resistant Bacteria Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Special Clinic Case Studies
Figure 8. Recovery Center Case Studies
Figure 9. Multidrug Resistant Bacteria Treatment Report Years Considered
Figure 10. Global Multidrug Resistant Bacteria Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Multidrug Resistant Bacteria Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Multidrug Resistant Bacteria Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Multidrug Resistant Bacteria Treatment Market Share by Regions (2022-2027)
Figure 14. Global Multidrug Resistant Bacteria Treatment Market Share by Players in 2020
Figure 15. Global Top Multidrug Resistant Bacteria Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multidrug Resistant Bacteria Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Multidrug Resistant Bacteria Treatment Revenue in 2020
Figure 17. Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Multidrug Resistant Bacteria Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Multidrug Resistant Bacteria Treatment Market Share by Type (2016-2027)
Figure 21. North America Multidrug Resistant Bacteria Treatment Market Share by Application (2016-2027)
Figure 22. North America Multidrug Resistant Bacteria Treatment Market Share by Country (2016-2027)
Figure 23. United States Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Multidrug Resistant Bacteria Treatment Market Share by Type (2016-2027)
Figure 27. Europe Multidrug Resistant Bacteria Treatment Market Share by Application (2016-2027)
Figure 28. Europe Multidrug Resistant Bacteria Treatment Market Share by Country (2016-2027)
Figure 29. Germany Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Multidrug Resistant Bacteria Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Multidrug Resistant Bacteria Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Multidrug Resistant Bacteria Treatment Market Share by Region (2016-2027)
Figure 39. China Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Multidrug Resistant Bacteria Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Multidrug Resistant Bacteria Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Multidrug Resistant Bacteria Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Multidrug Resistant Bacteria Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Multidrug Resistant Bacteria Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Multidrug Resistant Bacteria Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Multidrug Resistant Bacteria Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Nabriva Therapeutics Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 59. BioVersys Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 61. Destiny Pharma Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 62. Armata Pharmaceuticals Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 63. Westway Health Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 64. Nemesis Bioscience Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 65. Tetraphase Pharmaceuticals Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 66. Allergan Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 69. CARB-X Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 70. Melinta Therapeutics Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 71. Novartis Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 72. Vertex Pharmaceuticals Incorporated Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 73. GlaxoSmithKline Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 74. AbbVie Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 75. Roche Revenue Growth Rate in Multidrug Resistant Bacteria Treatment Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

以下、関連資料のご紹介

世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年）

Global Castrate-resistant Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3976 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、去勢抵抗性前立腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、免疫療法、放射線療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の治療抵抗性うつ病市場規模・現状・予測（2021年-2027年）

Global Treatment Resistant Depression Market Size, Status and Forecast 2021-2027
QFJ1-4982 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、治療抵抗性うつ病の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（選択的セロトニン再取り込み阻害剤、モノアミン酸化酵素阻害剤、三環系抗うつ薬、エスケタミン点鼻薬）、用途別市場規模（病院、クリニック、その...

世界の去勢抵抗性前立腺がん（CRPC）/ HRPCA治療薬市場規模・現状・予測（2021年-2027年）

Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3977 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、去勢抵抗性前立腺がん（CRPC）/ HRPCA治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口療法、注射療法）、用途別市場規模（病院＆診療所、家庭用、外来手術センター（ASC））、主要地域別...

世界のバンコマイシン耐性腸球菌フェシウム治療薬市場規模・現状・予測（2021年-2027年）

Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size, Status and Forecast 2021-2027
QFJ1-5719 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、バンコマイシン耐性腸球菌フェシウム治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ダプトマイシン、リネゾリド、キヌプリスチン/ダルホプリスチン、アンピシリン、クロラムフェニコール、その他）、用途...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の難燃性ポリウレタン市場規模・現状・予測（2021年-2027年）

Global Flame-Resistant Polyurethanes Market Size, Status and Forecast 2021-2027
QFJ1-2345 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、難燃性ポリウレタンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（難燃性ポリウレタンフォーム、難燃性ポリウレタン液体、難燃性ポリウレタン繊維）、用途別市場規模（輸送、建設、家具、電気＆電子）、主要地域...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年） Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Many early-stage prostate cancers need normal levels of testosterone to grow, but castrate-resistant prostate cancers do not. Also called CRPC. Market Analysis and Insights: Global Cast…
世界の治療抵抗性うつ病市場規模・現状・予測（2021年-2027年） Depression if untreated at an early stage may prove fatal often resulting in suicidal tendency in ailing patients. According to the statistics provided by World Health Organization (WHO), each year 800,000 people die due to suicide. It is important for physicians to perform accurate diagnosis and id…
世界の去勢抵抗性前立腺がん（CRPC）/ HRPCA治療薬市場規模・現状・予測（2021年-2027年） Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining prominence in the prostate cancer market. The global CRPC market is poised to expand at a signi…
世界のバンコマイシン耐性腸球菌フェシウム治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market The global Drugs for Vancomycin-Resistant Enterococcus Faecium market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-stand…
世界の難燃性ポリウレタン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Flame-Resistant Polyurethanes Market The global Flame-Resistant Polyurethanes market size is projected to reach US$ 23170 million by 2027, from US$ 16980 million in 2020, at a CAGR of 4.1% during 2021-2027. With industry-standard accuracy in analysis and high dat…